521 related articles for article (PubMed ID: 17662905)
21. In vivo evaluation of piperine and synthetic analogues as potential treatments for vitiligo using a sparsely pigmented mouse model.
Faas L; Venkatasamy R; Hider RC; Young AR; Soumyanath A
Br J Dermatol; 2008 May; 158(5):941-50. PubMed ID: 18284389
[TBL] [Abstract][Full Text] [Related]
22. Autologous cellular suspensions and sheets in the treatment of achromic disorders: the need for future controlled studies.
Ongenae K; van Geel N; Naeyaert JM
Dermatology; 2001; 202(2):158-61. PubMed ID: 11306847
[TBL] [Abstract][Full Text] [Related]
23. Vitiligo surgical, laser, and alternative therapies: a review and case series.
Wassef C; Lombardi A; Khokher S; Rao BK
J Drugs Dermatol; 2013 Jun; 12(6):685-91. PubMed ID: 23839187
[TBL] [Abstract][Full Text] [Related]
24. Retinoic acid synergistically enhances the melanocytotoxic and depigmenting effects of monobenzylether of hydroquinone in black guinea pig skin.
Kasraee B; Fallahi MR; Ardekani GS; Ebrahimi S; Doroudchi G; Omrani GR; Handjani F; Amini M; Tanideh N; Haddadi M; Nikbakhsh M; Jahanbani S; Tran C; Sorg O; Saurat JH
Exp Dermatol; 2006 Jul; 15(7):509-14. PubMed ID: 16761959
[TBL] [Abstract][Full Text] [Related]
25. Phototherapy for vitiligo, what's new?
Paro Vidolin A; Aurizi C; Leone G
G Ital Dermatol Venereol; 2017 Oct; 152(5):474-488. PubMed ID: 28906087
[TBL] [Abstract][Full Text] [Related]
26. Controversial issues in vitiligo patients: a review of old and recent treatments.
Lotti T; Gianfaldoni S; Valle Y; Rovesti M; Feliciano C; Satolli F
Dermatol Ther; 2019 Jan; 32(1):e12745. PubMed ID: 30221810
[TBL] [Abstract][Full Text] [Related]
27. Treatment of vitiligo on difficult-to-treat sites using autologous noncultured cellular grafting.
Mulekar SV; Al Issa A; Al Eisa A
Dermatol Surg; 2009 Jan; 35(1):66-71. PubMed ID: 19076191
[TBL] [Abstract][Full Text] [Related]
28. [Phototherapy with UV-B in vitiligo].
Köster W; Wiskemann A
Z Hautkr; 1990 Nov; 65(11):1022-4, 1029. PubMed ID: 2080652
[TBL] [Abstract][Full Text] [Related]
29. Spontaneous repigmentation in vitiligo: why it is important.
Malakar S; Lahiri K
Int J Dermatol; 2006 Apr; 45(4):478-9. PubMed ID: 16650185
[No Abstract] [Full Text] [Related]
30. Prospective comparison of recipient-site preparation with fractional carbon dioxide laser vs. dermabrasion and recipient-site dressing composition in melanocyte-keratinocyte transplantation procedure in vitiligo: a preliminary study.
Silpa-Archa N; Griffith JL; Williams MS; Lim HW; Hamzavi IH
Br J Dermatol; 2016 Apr; 174(4):895-7. PubMed ID: 26409069
[No Abstract] [Full Text] [Related]
31. Comparison between 308-nm monochromatic excimer light and narrowband UVB phototherapy (311-313 nm) in the treatment of vitiligo--a multicentre controlled study.
Casacci M; Thomas P; Pacifico A; Bonnevalle A; Paro Vidolin A; Leone G
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):956-63. PubMed ID: 17659006
[TBL] [Abstract][Full Text] [Related]
32. Melanocyte transplantation for the treatment of vitiligo: effects of different surgical techniques.
Issa CM; Rehder J; Taube MB
Eur J Dermatol; 2003; 13(1):34-9. PubMed ID: 12609779
[TBL] [Abstract][Full Text] [Related]
33. Long-term follow-up study of segmental and focal vitiligo treated by autologous, noncultured melanocyte-keratinocyte cell transplantation.
Mulekar SV
Arch Dermatol; 2004 Oct; 140(10):1211-5. PubMed ID: 15492183
[TBL] [Abstract][Full Text] [Related]
34. Targeted and combination treatments for vitiligo. Comparative evaluation of different current modalities in 458 subjects.
Lotti T; Buggiani G; Troiano M; Assad GB; Delescluse J; De Giorgi V; Hercogova J
Dermatol Ther; 2008 Jul; 21 Suppl 1():S20-6. PubMed ID: 18727812
[TBL] [Abstract][Full Text] [Related]
35. New and emerging therapies for vitiligo.
Halder RM; Young CM
Dermatol Clin; 2000 Jan; 18(1):79-89, ix. PubMed ID: 10626114
[TBL] [Abstract][Full Text] [Related]
36. Review of current clinical studies of vitiligo treatments.
Korobko IV
Dermatol Ther; 2012; 25 Suppl 1():S17-27. PubMed ID: 23237034
[TBL] [Abstract][Full Text] [Related]
37. Disorders of Hypopigmentation.
Dina Y; McKesey J; Pandya AG
J Drugs Dermatol; 2019 Mar; 18(3):s115-s116. PubMed ID: 30909355
[TBL] [Abstract][Full Text] [Related]
38. An update on new and emerging options for the treatment of vitiligo.
Mahmoud BH; Hexsel CL; Hamzavi IH
Skin Therapy Lett; 2008 Mar; 13(2):1-6. PubMed ID: 18373041
[TBL] [Abstract][Full Text] [Related]
39. Tissue-engineered skin in the treatment of vitiligo lesions.
Arenberger P; Broz L; Veselý P; Havlícková B; Matousková E
Folia Biol (Praha); 2000; 46(4):157-60. PubMed ID: 10954161
[TBL] [Abstract][Full Text] [Related]
40. Vitiligo: current medical and scientific understanding.
Boissy RE; Nordlund JJ
G Ital Dermatol Venereol; 2011 Feb; 146(1):69-75. PubMed ID: 21317859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
